By Peter NurseInvesting.com -- European stock markets traded largely unchanged Thursday, with investors displaying caution ahead of Friday’s key U.S. payrolls release while...
(Reuters) - European shares rose on Tuesday after a strong rally last week, as better-than-expected trade data from China added to relief from early signs that sweeping lockdown...
(Reuters) - European shares were flat on Wednesday ahead of the signing of an initial Sino-U.S. trade deal, as comments from the U.S. Treasury Secretary that tariffs on China would...
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others. On September 9, 2013, the Company acquired the full rights to develop and commercialize Kineret (anakinra) from Amgen, the biotechnology company based in the United States.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Sell | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 512.50 | 512.50 | 512.50 | 0.00 | 0.00% | 0.00 | London | |||
| 127.36 | 127.76 | 126.32 | +0.70 | +0.55% | 76.46M | London | |||
| 6,228.00 | 6,248.00 | 6,134.00 | +58.0 | +0.94% | 596.69K | London | |||
| 1,874.00 | 1,897.00 | 1,836.00 | +11.0 | +0.59% | 738.01K | London | |||
| 3,743.00 | 3,776.00 | 3,668.00 | +19.0 | +0.51% | 355.69K | London | |||
| 5.49 | 5.50 | 5.49 | 0.00 | 0.00% | 0.00 | London | |||
| 138.20 | 141.20 | 133.35 | +2.70 | +1.99% | 3.70M | London | |||
| 97.50 | 95.00 | 95.00 | +0.50 | +0.52% | 724.72K | London | |||
| 442.30 | 452.90 | 441.70 | -4.80 | -1.07% | 1.74M | London | |||
| 1,864.50 | 1,877.00 | 1,818.00 | +42.5 | +2.33% | 1.12M | London | |||
| 318.00 | 321.00 | 306.00 | +9.20 | +2.98% | 599.66K | London | |||
| 243.30 | 250.30 | 241.60 | -6.50 | -2.60% | 3.43M | London | |||
| 2,234.00 | 2,258.00 | 2,217.00 | -10.0 | -0.45% | 365.37K | London | |||
| 0.70 | 0.748 | 0.70 | -0.002 | -0.27% | 5.78M | London | |||
| 278.50 | 282.00 | 278.50 | -0.50 | -0.18% | 322.69K | London |